Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Danbury, Connecticut
- Most recent report
- 8-K, filed Aug 21, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 899460
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 55
News 8 of 186
Prospectuses and Registrations 8 of 22
- S-3ASR Automatic shelf registration Feb 26, 2025
- S-8 Registration statement for an employee plan Aug 23, 2023
- S-3ASR Automatic shelf registration Feb 24, 2022
- S-8 Registration statement for an employee plan Aug 7, 2020
- 424B5 Prospectus supplement for an offering May 7, 2019
- S-3 Shelf registration statement Mar 29, 2019
- 424B5 Prospectus supplement for an offering Dec 21, 2018
- 424B5 Prospectus supplement for an offering Dec 19, 2018
Proxies 8 of 33
- DEFA14A Extra proxy material Apr 7, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 7, 2026
- DEFA14A Extra proxy material Apr 1, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 1, 2025
- DEFA14A Extra proxy material Apr 5, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 5, 2024
- DEFA14A Extra proxy material Apr 14, 2023
- DEFA14A Extra proxy material Apr 11, 2023
Ownership 8 of 661
- 4 Insider reported a trade Sep 28, 2026
- 144 Notice of a proposed sale of restricted stock Sep 25, 2026
- 4 Insider reported a trade Sep 14, 2026
- 144 Notice of a proposed sale of restricted stock Sep 10, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- 4 Insider reported a trade Aug 10, 2026
- 144 Notice of a proposed sale of restricted stock Aug 7, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 31, 2026
Other 8 of 43
Everything here comes from Mannkind Corp's own filings on SEC EDGAR. The filing list is rechecked every hour.